Literature DB >> 2705310

Low pH-dependent Sindbis virus-induced fusion of BHK cells: differences between strains correlate with amino acid changes in the E1 glycoprotein.

W M Boggs1, C S Hahn, E G Strauss, J H Strauss, D E Griffin.   

Abstract

Expression of alphavirus glycoproteins on the surface of infected cells leads to cell fusion after exposure to acidic pH. Two strains of Sindbis virus, AR339 (SV) and neuroadapted Sindbis virus (NSV), which differ in virulence for weanling mice, were found to differ in pH-dependent fusion. BHK-21 cells infected with SV fused maximally after shifting to pH 5.4, whereas cells infected with NSV required a lower pH, pH 4.8, for maximal fusion. No difference was noted in the optimal pH for agglutination of goose erythrocytes (5.75 for both viruses). To determine the molecular basis for the difference in fusion a series of recombinant viruses was constructed using a cDNA clone of Sindbis virus from which infectious RNA can be transcribed in vitro. Cells infected with a recombinant virus that had the SV E1 and NSV E2 genes had a fusion response curve as a function of pH like SV, while cells infected with recombinant virus with the NSV E1 and SV E2 genes fused like NSV. The E1 glycoproteins of SV and NSV differ at two positions: Val-72 in SV is Ala in NSV (a change near the putative fusion site), and Gly-313 in SV is Asp in NSV. Recombinant viruses which had Val-72 (SV) and Asp-313 (NSV) or Ala-72 (NSV) and Gly-313 (SV) had a lowered pH of fusion like NSV suggesting that both positions participate in determining some aspect of the conformational change in the E1-E2 heterodimer associated with pH-dependent fusion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705310     DOI: 10.1016/0042-6822(89)90178-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes.

Authors:  J M Smit; R Bittman; J Wilschut
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein.

Authors:  P Levy-Mintz; M Kielian
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Spike protein oligomerization control of Semliki Forest virus fusion.

Authors:  M Lobigs; J M Wahlberg; H Garoff
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Attenuating mutations in glycoproteins E1 and E2 of Sindbis virus produce a highly attenuated strain when combined in vitro.

Authors:  J M Polo; R E Johnston
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  fus-1, a pH shift mutant of Semliki Forest virus, acts by altering spike subunit interactions via a mutation in the E2 subunit.

Authors:  S Glomb-Reinmund; M Kielian
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Suppressors of cleavage-site mutations in the p62 envelope protein of Semliki Forest virus reveal dynamics in spike structure and function.

Authors:  I Tubulekas; P Liljeström
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Amino acid changes in the Sindbis virus E2 glycoprotein that increase neurovirulence improve entry into neuroblastoma cells.

Authors:  P C Tucker; S H Lee; N Bui; D Martinie; D E Griffin
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 8.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

9.  Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.

Authors:  M Salvato; P Borrow; E Shimomaye; M B Oldstone
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

10.  Structural rearrangement of infecting Sindbis virions at the cell surface: mapping of newly accessible epitopes.

Authors:  W J Meyer; R E Johnston
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.